[home]
[thesaurus]
Click Here to return To Results
Rituximab Treatment for Autoimmune Limbic Encephalitis in an Institutional Cohort
Neurol 86:1683-1691,1655, Lee, W.J.,et al, 2016
See this aricle in Pubmed
Article Abstract
Rituximab is effective and safe as a second-line immunotherapy for ALE, regardless of autoantibody status. Additional monthly rituximab therapy might potentiate the efficacy of rituximab.
Related Tags
(click to filter results - removes previous filter)
efficacy
encephalitis,autoimmune
immunotherapy
limbic encephalitis
monoclonal antibodies
rituximab
safety
treatment of neurologic disorder
Click Here to return To Results